BACE2 and Alzheimer disease: The present study considers the separate and concurrently combined implementations of the suppression of the neuronal integrated stress response and of the targeted degradation of iAβ via the activation of BACE1 and/or BACE2 (or by other suitable agents) in the contexts of both conventional and unconventional Alzheimer’s disease.